WASHINGTON (Reuters) – U.S. President Donald Trump continues to see a malaria drug, hydroxychloroquine, as a promising drug to be used to prevent infection with the coronavirus, the White House said on Thursday, though the U.S. Food and Drug Administration has said its efficacy and safety were unproven.
“The president has always said that he sees hydroxychloroquine as a very promising prophylactic but that every person should not take it unless they get a prescription from their doctor,” White House spokeswoman Kayleigh McEnany said at a news conference.
(Reporting by Jeff Mason; Writing by Makini Brice; Editing by Chizu Nomiyama)
